YOLFTbeta
Medipharm Labs Corp

Medipharm Labs Corp

LABS · TO · Healthcare / Drug Manufacturers - Specialty & Generic

0.065CAD-0.01 (-7.14%)

Price History

Full chart

Market Stats

Previous Close0.07
Open0.065
Day Range0.065 – 0.07
52-Week Range0.06 – 0.10
Volume115.66K
Market Cap29.90M
P/E (TTM)0.00
Forward P/E27.47
EPS-0.01
Dividend Yield0.00%
Beta0.93
50-Day Avg0.0746
200-Day Avg0.0725

About

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Greg Hunter
  • Employees127
  • Headquarters151 John Street, Barrie, ON, Canada, L4N 2L1, Canada
  • Websitehttps://www.medipharmlabs.com

Leadership

  • Mr. Keith StrachanCo-Founder & Chair of the Board
  • Mr. Greg HunterCFO & Interim CEO
  • Mr. Kirk BinnsExecutive Vice President of Global Accounts

Financials

Income Statement

Currency: CAD2016-12-312017-12-312018-09-302018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--010.20M129.25M36.01M21.71M22.12M33.06M41.96M45.12M
Growth (%)----+1167.42%-72.14%-39.71%+1.87%+49.49%+26.92%+7.54%
Cost of Revenue---6.23M86.34M79.99M36.96M24.03M27.21M29.16M31.16M
Gross Profit---3.97M42.91M-43.98M-15.25M-1.91M5.86M12.80M13.97M
Gross Margin---38.90%33.20%-122.12%-70.22%-8.65%17.71%30.52%30.95%
Operating Expense---11.99M35.98M28.60M33.67M27.62M24.11M23.61M22.38M
Operating Income-133.94K-948.00K-213.54K-8.03M6.94M-72.58M-48.92M-29.53M-18.25M-10.81M-8.41M
Operating Margin----78.71%5.37%-201.53%-225.31%-133.53%-55.21%-25.76%-18.63%
EBITDA--42.00K--7.00M9.72M-53.40M-38.55M-27.09M-10.48M-7.52M-6.54M
EBITDA Margin----68.63%7.52%-148.28%-177.56%-122.47%-31.69%-17.92%-14.50%
Net Income-133.94K-990.00K-211.10K-8.41M1.13M-67.11M-54.80M-29.98M-13.08M-10.69M-8.27M
Net Income Margin----82.48%0.88%-186.35%-252.41%-135.57%-39.57%-25.49%-18.32%
R&D---261.00K867.00K2.23M1.35M1.00M209.00K235.00K223.00K
R&D as % of Total Revenue---2.56%0.67%6.18%6.24%4.53%0.63%0.56%0.49%
Interest Expense000478.00K672.00K7.88M10.51M31.00K365.00K576.00K63.00K
Interest Expense % of Total Revenue---4.69%0.52%21.87%48.39%0.14%1.10%1.37%0.14%

Balance Sheet

Currency: CAD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets262.19K400.00K42.73M168.83M118.23M92.36M65.50M63.94M53.73M45.74M
Total Liabilities46.73K2.52M14.89M37.60M39.82M9.21M9.49M10.93M10.55M9.93M
Total Equity215.46K400.00K27.65M131.55M78.41M83.15M56.01M53.01M43.18M35.81M
Cash262.19K400.00K7.85M38.63M19.91M34.11M24.14M17.98M11.69M10.81M
Total Debt24.86K1.21M6.00M10.58M18.46M216.00K632.00K2.29M388.00K201.00K
Net Debt-237.32K813.00K-1.85M-28.05M-1.46M-33.89M-23.51M-15.69M-11.30M-10.61M

Cash Flow

Currency: CAD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-54.69K166.00K-11.11M-25.27M-37.77M-13.21M-16.07M-12.34M-4.86M-5.50M
Investing Cash Flow-2.19M-2.19M-14.60M-32.55M-7.45M35.00K5.16M6.87M413.00K4.62M
Financing Cash Flow316.83K4.26M31.06M88.50M26.42M27.80M796.00K-368.00K-1.85M-18.00K
Capital Expenditure2.14M2.14M14.57M32.44M7.50M783.00K863.00K471.00K154.00K100.00K
Free Cash Flow-54.69K-1.98M-25.68M-57.70M-45.28M-14.00M-16.93M-12.81M-5.01M-5.60M
Dividends Paid---0000000
FCF to OCF100.00%-1191.57%231.13%228.39%119.86%105.93%105.37%103.82%103.17%101.82%
Dividend Paid to FCF---0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateFeb 19, 2019May 10, 2019Aug 12, 2019Nov 12, 2019Mar 30, 2020Jun 18, 2020Aug 13, 2020Nov 16, 2020Mar 31, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 31, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 27, 2024May 15, 2024Aug 14, 2024Nov 14, 2024Mar 31, 2025May 14, 2025Aug 14, 2025Nov 13, 2025Mar 30, 2026May 13, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate-0.010.010.010.030.02-0.01-0.04-0.03-0.03-0.05-0.03-0.03-0.02-0.03-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.01---------
EPS Actual0.01-0.010.010.02-0.01-0.03-0.03-0.05-0.21-0.09-0.05-0.03-0.08-0.03-0.03-0.03-0.02-0.01-0.03-0.01-0.01-0.01-0.01-0.01-0.01-0.00-0.01-0.01-0.00-0.000.00-
Surprise200.00%-200.00%0.00%-33.33%-150.00%-200.00%25.00%-66.67%-600.00%-80.00%-66.67%0.00%-300.00%0.00%-50.00%-50.00%-100.00%0.00%-200.00%0.00%0.00%0.00%0.00%---------
TimingPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market

Key Statistics & Ratios

Market Cap29.90M
Enterprise Value22.61M
Trailing P/E0.00
Forward P/E27.47
Price / Sales0.72
Price / Book0.90
EPS-0.01
Book Value0.083
Revenue (TTM)41.46M
Gross Profit (TTM)13.14M
EBITDA-2.41M
Profit Margin-12.00%
Operating Margin0.82%
Return on Equity-13.22%
Return on Assets-5.17%
Shares Outstanding427.18M
Shares Float390.00M
Beta0.93
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%